FerlayJ, Steliarova-FoucherE, Lorte-TielentJet al.Cancer incidence and mortality patterns in Europe; Estimates for 40 countries in 2012. Eur J Cancer, 2013; 49:1374–1403.
2.
SiegelR, NaishadhamD, JemalA. Cancer Statistics, 2013. CA Cancer J Clin, 2013; 63:11–30.
3.
SobinLH, WittekindCH. TNM Classification of malignant tumours, 6th. New York: Wiley-Liss, 2002; 199–202.
4.
SylvesterRJ, van der MeijdenAP, OosterlinckWet al.Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials. Eur Urol, 2006; 49:466–477.
5.
BrausiM, ColletteL, KurthKet al.Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: A combined analysis of seven EORTC studies. Eur Urol, 2002; 41:523–531.
6.
MowattG, N'DowJ, ValeLet al.Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: Systematic review and meta-analysis. Int J Technol Assess Health Care, 2011; 27:3–10.
7.
StenzlA, PenkoffH, Dajc-SommererEet al.Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy: A multicenter randomized, double-blind, pacebo-controlled trial. Cancer, 2011; 117:938–947.
8.
CaubergEC, KloenS, VisserMet al.Narrow band imaging cystoscopy improves the detection of non-muscle-invasive bladder cancer. Urology, 2010; 76:658–663.
